Activists and academics discussed future of the access to medicines movement at the Global Summit on Intellectual Property and Access to Medicines in Istanbul at the end of July

While the recently cancelled WTO Ministerial Council was supposed to discuss the TRIPS waiver, its agenda included other topics that should be taken seriously by health activists